🚀 VC round data is live in beta, check it out!
- Public Comps
- Episurf Medical
Episurf Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Episurf Medical and similar public comparables like Genomtec, Biosynex, Polyrizon, Iridex and more.
Episurf Medical Overview
About Episurf Medical
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint.
Founded
2009
HQ

Employees
27
Website
Sectors
Financials (FY)
EV
$19M
Episurf Medical Financials
Episurf Medical reported last fiscal year revenue of $1M and negative EBITDA of ($5M).
In the same fiscal year, Episurf Medical generated $1M in gross profit, ($5M) in EBITDA losses, and had net loss of ($6M).
Episurf Medical P&L
In the most recent fiscal year, Episurf Medical reported revenue of $1M and EBITDA of ($5M).
Episurf Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $1M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $1M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 75% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($5M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (365%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (428%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($6M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (431%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Episurf Medical Stock Performance
Episurf Medical has current market cap of $19M, and enterprise value of $19M.
Market Cap Evolution
Episurf Medical's stock price is $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19M | $19M | 0.3% | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEpisurf Medical Valuation Multiples
Episurf Medical trades at 13.0x EV/Revenue multiple, and (3.6x) EV/EBITDA.
Episurf Medical Financial Valuation Multiples
As of April 20, 2026, Episurf Medical has market cap of $19M and EV of $19M.
Equity research analysts estimate Episurf Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Episurf Medical has a P/E ratio of (3.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $19M | XXX | $19M | XXX | XXX | XXX |
| EV (current) | $19M | XXX | $19M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 13.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (3.6x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (3.0x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 17.4x | XXX | XXX | XXX |
| P/E | — | XXX | (3.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (2.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Episurf Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Episurf Medical Margins & Growth Rates
Episurf Medical's revenue in the last fiscal year grew by 4%.
Episurf Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Episurf Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (365%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (25%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 503% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Episurf Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Episurf Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Genomtec | XXX | XXX | XXX | XXX | XXX | XXX |
| Biosynex | XXX | XXX | XXX | XXX | XXX | XXX |
| Polyrizon | XXX | XXX | XXX | XXX | XXX | XXX |
| Iridex | XXX | XXX | XXX | XXX | XXX | XXX |
| Wellgistics Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Episurf Medical M&A Activity
Episurf Medical acquired XXX companies to date.
Last acquisition by Episurf Medical was on XXXXXXXX, XXXXX. Episurf Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Episurf Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEpisurf Medical Investment Activity
Episurf Medical invested in XXX companies to date.
Episurf Medical made its latest investment on XXXXXXXX, XXXXX. Episurf Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Episurf Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Episurf Medical
| When was Episurf Medical founded? | Episurf Medical was founded in 2009. |
| Where is Episurf Medical headquartered? | Episurf Medical is headquartered in Sweden. |
| How many employees does Episurf Medical have? | As of today, Episurf Medical has over 27 employees. |
| Who is the CEO of Episurf Medical? | Episurf Medical's CEO is Pal Ryfors. |
| Is Episurf Medical publicly listed? | Yes, Episurf Medical is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Episurf Medical? | Episurf Medical trades under EPIS B ticker. |
| When did Episurf Medical go public? | Episurf Medical went public in 2010. |
| Who are competitors of Episurf Medical? | Episurf Medical main competitors are Genomtec, Biosynex, Polyrizon, Iridex. |
| What is the current market cap of Episurf Medical? | Episurf Medical's current market cap is $19M. |
| What is the current revenue of Episurf Medical? | Episurf Medical's last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Episurf Medical? | Current revenue multiple of Episurf Medical is 13.0x. |
| Is Episurf Medical profitable? | No, Episurf Medical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.